Abstract
The biological characteristics, morphology, and genomic information of Lactobacillus delbrueckii subsp. sunkii, isolated from the vaginal secretions of pregnant women, have not yet been reported. Elucidating its biological properties and genetic functions may provide a theoretical foundation for developing probiotic preparations to treat bacterial vaginosis. The strain was identified as L. delbrueckii subsp. sunkii using mass spectrometry and 16S ribosomal RNA (16S rRNA) gene sequencing. Colony morphology was observed, Gram staining characteristics were examined, and cellular ultrastructure was visualized via scanning electron microscopy (SEM). Whole-genome sequencing was performed using both second- and third-generation sequencing platforms, followed by comprehensive bioinformatics analysis. Additionally, biochemical experiments, H2O2 production tests, acid production assays, antibacterial activity assays, and antimicrobial susceptibility tests were conducted. The strain is a Gram-positive, rod-shaped, facultative anaerobe that possesses sparse filamentous, white, spine-like pili on its surface. It efficiently ferments sugars to produce acid but does not produce H2O2. While susceptible to 7 common antibiotics, it is resistant to sulfonamides. It inhibits the growth of Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae, and produces α-hemolytic rings on blood agar. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Clusters of Orthologous Groups (COG) annotations indicated that the strain is primarily involved in metabolic pathways. The Comprehensive Antibiotic Resistance Database (CARD) annotated 10 antibiotic resistance genes, including those for macrolides, tetracyclines, peptides, lincosamides, glycopeptides, penams, fluoroquinolones, streptogramins, nitroimidazoles, and pleuromutilins. L. delbrueckii subsp. sunkii exhibits strain-dependent variations in morphology, biochemical reactions, and nucleotide sequences. H2O2 production is not a universal feature among strains of this subspecies. It exhibits strong acid production from sugars and high susceptibility to most antibiotics, but shows a genotype-phenotype discrepancy in resistance, as sulfonamides do not inhibit its growth. These findings suggest that this subspecies may be associated with human metabolism and vaginal microbiota balance. However, further animal studies are needed to confirm its functional significance in the human vaginal environment.
Introduction
Lactic acid bacteria colonize the human gastrointestinal and urogenital tracts and are integral to human microbial communities [1]. L. delbrueckii, a key species within the genus Lactobacillus, comprises six subspecies: L. delbrueckii subsp. delbrueckii, L. delbrueckii subsp. lactis, L. delbrueckii subsp. bulgaricus, L. delbrueckii subsp. indicus, L. delbrueckii subsp. sunkii, and L. delbrueckii subsp. jakobsenii [2–4]. Studies have shown that the six subspecies of L. delbrueckii differ in their repertoires of subspecies-specific gene gains and losses [5]. Horizontal gene transfer analyses indicated that frequent gene transfers occurred between different subspecies when they first diverged from the common ancestor, but recent gene exchanges have remained confined to individual subspecies, implying that the six subspecies have undergone independent evolutionary processes since then. The subspecies lactis, jakobsenii, delbrueckii, and sunkii were more closely related to each other than to the bulgaricus and indicus subspecies. These four subspecies all show increasing genetic variability with increasing genome size; they can be distinguished by their specific gene contents. Carbohydrate metabolism in L. delbrueckii subsp. bulgaricus is primarily focused on lactose fermentation and a small range of additional carbohydrates. In contrast, L. delbrueckii subsp. lactis is capable of fermenting a variety of plant-derived sugars, such as maltose, mannose, sucrose, and trehalose. Meanwhile, L. delbrueckii subsp. sunkii and L. delbrueckii subsp. jakobsenii are negative for lactose fermentation. Numerous studies have focused on L. delbrueckii, yet most have concentrated on L. delbrueckii subsp. bulgaricus [6] and L. delbrueckii subsp. lactis [7], while research on L. delbrueckii subsp. sunkii remains scarce. Current investigations into this species have predominantly targeted applications in the food industry [8,9] and animal husbandry [10,11], with minimal exploration into disease prevention, therapy, or clinical healthcare. Based on phylogenetic trees constructed from amplified fragment length polymorphism (AFLP) profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) patterns, Kudo et al. [3] identified L. delbrueckii subsp. sunkii as a novel subspecies. However, their study was limited to morphological, physiological, and biochemical characterizations of the strains, and did not include detailed analyses of their whole-genome sequences, gene function annotations, or ultrastructural morphology. In accordance with Rule 54 of the International Code of Nomenclature of Prokaryotes, Goo et al. [12] proposed L. delbrueckii subsp. allosunkii nom. nov. as a replacement name for L. delbrueckii subsp. sunkii in 2024, which was originally reported by Kudo et al. [3] in 2012. The literature databases contain limited information on L. delbrueckii subsp. sunkii, particularly regarding strains derived from vaginal secretions of pregnant women—a finding not previously reported. Indeed, there are few reports on the unique value and significance of L. delbrueckii subsp. sunkii in the vaginal microbiota. To investigate the role of this bacterium in disease prevention and treatment, we isolated and cultured it in a preliminary study and examined its biological characteristics, including morphological and structural features, culture characteristics, and biochemical reactions. Additionally, we completed whole-genome nucleotide sequencing and annotated its gene functions, including resistance genes and signaling pathways. These efforts help fill a gap in this field. Moreover, by examining the morphological, biological, and genomic properties described above, along with in vitro acid production tests, antibacterial activity tests, and antimicrobial susceptibility tests, our study provides a foundation for the subsequent construction of antibacterial animal models and further exploration of resistance mechanisms.
Materials and methods
Study subjects
This project was approved by the Ethics Committee of Shenzhen Yantian District People’s Hospital and the Health Bureau of Yantian District, Shenzhen (No. YTWS 20230203). The study was conducted with the informed consent of the patients and in accordance with the principles of the Declaration of Helsinki. From September 1 to November 30, 2020, a total of 15 third-trimester pregnant women were recruited from the obstetric outpatient clinic of Yantian District People’s Hospital in Shenzhen. The third trimester of pregnancy is defined as the period from 28 weeks of gestation until delivery. The included participants were aged 25–35 years, with a gestational age of 35 ± 4 weeks. Exclusion criteria included clinical gynecological inflammation, abnormal vaginal microbiome, fetal developmental abnormalities, or recent antibiotic use. All participants provided written informed consent.
Sample collection and isolation
A sterile cotton swab (Jiangsu Kangjian, China) was used to gently rotate and collect secretions from the posterior vaginal fornix of pregnant women, and the swab was immediately streaked onto MRS blood agar plates in designated sectors. The plates were then incubated in an MCO-18 AC incubator (Panasonic, Japan) at 35 °C with 5% CO2 for 48 hours. Subsequently, suspected colonies were selected and subcultured on modified acidified blood agar plates containing 5% NaCl for further purification.
Observation of colony growth, bacterial morphology, and preliminary species identification
After 48 hours of incubation, colony growth was observed and Gram staining was performed. Additionally, a GeminiSEM 300 scanning electron microscope (ZEISS, Germany) was used to examine the bacterial ultrastructure. For SEM analysis, samples were coated with platinum using an ion sputter coater, placed in the microscope chamber, and examined at an acceleration voltage of 5 kV and a working distance of 4.8 mm after evacuation. Focusing, astigmatism correction, and contrast/brightness adjustments were performed prior to image acquisition. Pure colonies were selected for preliminary identification. According to the manufacturer’s instructions, a Microflex LT/SH mass spectrometer (Bruker Daltonics, Germany) was used following the steps below: (1) Sample preparation: Prepare the sample solution using formic acid and acetonitrile extraction. (2) Using a micropipette, spot 1 µL of the sample solution onto the target plate and allow it to air dry; then add 1 µL of alpha-cyano-4-hydroxycinnamic acid (CHCA) matrix solution dropwise and allow it to air-dry again before loading the plate into the instrument. (3) Calibrate the instrument. (4) Enter sample information. (5) Collect spectra, perform identification, and generate the report. (6) Clean the target plate.
H2O2 test, biochemical reaction tests, acid production test, antibacterial activity test, and antibiotic susceptibility test
For the H2O2 test, 50 µL of 3% H2O2 solution was placed on a clean glass slide. A colony of L. delbrueckii subsp. sunkii was picked using a sterile inoculation needle and mixed with the solution, and bubble formation was observed. For biochemical reaction tests, a bacterial suspension of L. delbrueckii subsp. sunkii adjusted to a 0.5 McFarland standard was prepared and inoculated into Gram-negative (GN) and Gram-positive (GP) identification cards (bioMérieux, France). For the acid production test, 1 mL of 5% glucose solution and 0.1 mL of 0.5 McFarland bacterial suspension were added to each of 10 tubes containing 5 mL of nutrient broth medium (Bohu Company, China). The antibacterial activity test was repeated three times using the spot-on-lawn method. The 0.5 McFarland bacterial suspension was spread on one side of a 9 cm blood agar plate. A standard strain of E. coli (ATCC 25922), S. aureus (ATCC 25923), or S. agalactiae (ATCC 13813) was picked with an inoculation needle and streaked onto the center of the streaked area. The same standard strain was also inoculated on the opposite side of the plate as a control. For the antibiotic susceptibility test, the 0.5 McFarland suspension of L. delbrueckii subsp. sunkii was swabbed onto blood agar plates following the Kirby-Bauer (K-B) method. A total of 20 antibiotic discs (Wenzhou Kangtai Biotechnology Co., Ltd., China) were tested in parallel, with five antibiotic discs placed on each plate. E. coli (ATCC 25922) and S. aureus (ATCC 25923) were used as quality control strains. Testing was performed strictly according to the instructions of the reagent kit manufactured by Zhuhai Dier Bioengineering Co., Ltd. (China). To each well of the DL-96STREP reagent plates, 100 µL of M-H broth containing 0.5 McFarland standard bacterial suspension was added. The plates were incubated at 35 °C for 24 hours, and the results were then read. Partial antimicrobial susceptibility testing was performed in strict accordance with the Clinical and Laboratory Standards Institute (CLSI) M45 (3rd Edition): Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. After 48 hours of incubation, the isolates were identified using GN and GP biochemical identification cards, and the biochemical reaction results were interpreted using a VITEK 2 Compact system (bioMérieux, France). Glucose concentration and pH in the nutrient broth were measured by the hexokinase method and potentiometry, using an AU5800 analyzer (Beckman, USA) and an ABL90 blood gas analyzer (Radiometer, Denmark), respectively. For these measurements, 1 mL of nutrient broth was centrifuged at 3,000 × g for 5 minutes, and 500 µL of the supernatant was then used for glucose and pH detection. The diameters of the inhibition zones were measured using a 0–150 mm digital caliper (Aerospace Ruibo, China) to determine susceptibility.
DNA extraction and sequencing
The colonies were scraped from the culture medium using sterile cotton swabs. Bacterial genomic deoxyribonucleic acid (DNA) was extracted in a biosafety cabinet, following the manufacturer’s instructions for the D3146 HiPure Bacterial DNA Kit (Magen, China). The specific operational steps were as follows: 1) Add the harvested bacterial cells to a mixture of 100 µL of Buffer STE Plus, 30 µL of Lysozyme, and 10 µL of RNase A, mix by inversion, and incubate at room temperature for 20 minutes. Then, add 200 mg of glass beads to the mixture and vortex at high speed for 15 minutes to lyse the bacteria. 2) After lysis, let the sample stand for 3 minutes, then transfer 250 µL of the supernatant to a new sterile centrifuge tube. Add 250 µL of Buffer DL and 10 µL of Proteinase K, mix by inversion, and digest at 70 °C for 10 minutes. 3) Add 250 µL of anhydrous ethanol to the tube, vortex for 30 seconds, then transfer the mixture to the HiPure DNA Mini Column and centrifuge at 10,000 × g for 2 minutes; discard the flow-through. 4) Add 500 µL of Buffer GW1 to the HiPure DNA Mini Column and centrifuge at 10,000 × g for 1 minute, discard the flow-through, then add 650 µL of Buffer GW2 for the second wash, centrifuge at 10,000 × g for 1 minute, and discard the flow-through. 5) Transfer the HiPure DNA Mini Column to a new 1.5-mL centrifuge tube, add 50 µL of Buffer AE (preheated to 70 °C) to the center of the column membrane, incubate for 3 minutes, and centrifuge at 10,000 × g for 1 minute to elute the DNA. The extracted bacterial genomic DNA was quantified using a microplate reader, and its integrity was verified by agarose gel electrophoresis. The qualified DNA was stored at −20 °C for future use.
16S rRNA gene amplification
In a 0.5 mL polymerase chain reaction (PCR) tube, 15 μL of Super Mix enzyme mixture was mixed with 1 μL each of the forward (27F) and reverse (1492R) primers (S1 Table), 1 μL DNA template, and 12 μL nuclease-free double-distilled water (ddH2O) to bring the final volume to 30 μL. The mixture was briefly pulsed at high speed for 5 s and subjected to PCR amplification under the following conditions: 96 °C for 5 min (initial denaturation); followed by 35 cycles of 96 °C for 20 s (denaturation), 62 °C for 20 s (annealing), 72 °C for 30 s (extension); followed by a final extension at 72 °C for 10 min; the amplification products were then held at 16 °C.
Detection, purification, and sequencing of 16S rRNA amplicons
The PCR products (3 μL) were electrophoresed on a 1.0% agarose gel to confirm the presence and intensity of bands of the expected size of approximately 1,500 base pairs (bp). Bands of the expected size were observed, and purification was performed using a magnetic bead-based purification kit (Shuomei Co., Ltd., China) according to the manufacturer’s protocol. The purified products were then subjected to Sanger sequencing.
Library preparation and quality control for HiSeq and PacBio platforms
Genomic DNA (100 ng) was sheared into fragments (<500 bp) using a Covaris S220 ultrasonicator. The fragments were subsequently end-repaired and ligated with sequencing adapters using the End Prep Enzyme Mix, and then purified with magnetic beads. Subsequently, amplification was performed using P5 and P7 primers (S1 Table). Library quality was examined using an Agilent 2100 Bioanalyzer (Agilent Technologies, USA), and library concentration was quantified using a Qubit 3.0 Fluorometer. Qualified libraries were used for cluster generation, and second-generation sequencing was conducted on the Illumina NovaSeq 6000 sequencer (Illumina, USA). For PacBio Sequel II third-generation sequencing (PacBio, USA), 5–10 µg of high-quality genomic DNA was sheared into fragments of approximately 10 kb using a Covaris g-TUBE. The SMRTbell library was constructed using the DNA Template Prep Kit. The validated SMRTbell library, combined with sequencing primers and polymerase, was loaded onto the PacBio Sequel platform by diffusion-based loading for sequencing according to data volume requirements.
Sequencing data processing and bioinformatics analysis
The Sanger sequencing results were analyzed and species identification was performed using the Basic Local Alignment Search Tool (BLAST) program available on the National Center for Biotechnology Information (NCBI) website. Additionally, MEGA (version 7.0) software was used to construct a phylogenetic tree based on the obtained 16S rRNA gene sequence of L. delbrueckii subsp. sunkii WuYi 2021−1 and the 12 most similar species sequences in the database. In a separate step, the raw image data from the HiSeq and PacBio sequencing platforms were processed using Bcl2fastq (version 2.20) for base calling. The raw sequencing data (Pass Filter Data) were further processed with the quality control software Cutadapt (version 1.9.1) to remove adapters and low-quality sequences, yielding high-quality clean data for downstream analysis. The de novo genome analysis workflow comprised the following five steps:
-
(1)
Data Quality Control: Adapter sequences and low-quality reads were removed from second-generation sequencing data, and reads shorter than 500 bp were filtered out from Single Molecule Real-Time (SMRT) third-generation sequencing data to obtain the final clean data. PCR-negative controls (water blanks) were included, with Q30 scores of ≥80%.
-
(2)
Genome Assembly and Correction: Firstly, we obtained preliminary assembly results from third-generation sequencing data using software such as HGAP4 [13], Falcon (version 0.3) [14], and Canu (version 0.7) [15]. We then compared the third-generation sequencing data with the assembly results and corrected them using Arrow. Afterwards, we compared the quality-filtered second-generation sequencing data to the assembly results and further corrected them using Pilon to obtain the final assembly results [16].
-
(3)
Genome Component Analysis: Functional genes were predicted using Prodigal (version 3.02) [17]. Non-coding ribonucleic acids (RNAs), including tRNAs and rRNAs, and repeats were annotated using tRNAscan, barrnap, and alignment against the Rfam (version 12.0) database.
-
(4)
Gene Function Annotation: The predicted coding genes were compared against protein sequences in various databases, including the Non-Redundant Protein Sequence Database (NR), KEGG, Gene Ontology (GO), COG, Carbohydrate-Active enZymes Database (CAZy), Protein families database (Pfam), Swiss-Prot, and CARD, using BLAST (version 2.2.31+) [18], to obtain gene function annotations.
-
(5)
Additional Analyses: Secretory proteins, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) arrays, and prophages were predicted. The genome circular map was generated using Circos (version 0.69) [19].
Benchmarking Universal Single-Copy Orthologs (BUSCO) version 5.4.7 was installed via Conda (conda install -c bioconda busco = 5.4.7). A bacterial lineage database was selected based on the QUality ASsessment Tool (QUAST) evaluation of the L. delbrueckii genome assembly, which met the N50 threshold. Open reading frames were predicted from the input FASTA genome, and HMMER was used with the lineage-specific HMM to identify conserved single-copy orthologs. Genes with an alignment score that was ≥ 90% of the HMM self-score and a length within 2 standard deviations of the family mean were classified as complete.
Virulence factor annotation using the virulence factor database
Homology searches were performed using DIAMOND v2.2.5 in BLASTP mode with the --very-sensitive parameter and an E-value cutoff of 1 × 10-5. The predicted protein sequences of the L. delbrueckii subsp. sunkii strain were queried against the Virulence Factor Database (VFDB) Set A (core) and Set B (complete) protein datasets (VFDB: https://www.mgc.ac.cn/VFs) [20,21].
Results
Colony morphology and staining characteristics
L. delbrueckii subsp. sunkii formed moist, glistening colonies on modified blood agar plates, with smooth margins, slightly raised edges, and a depressed center, and exhibited α-hemolysis (S1 Fig). Under light microscopy, the subspecies displayed a Gram-positive, long rod-shaped morphology (Fig 1). SEM revealed bacterial cells of varying lengths and sizes, approximately 1–10 μm long (Fig 2). Additionally, the bacterial cell surface was covered with sparse filamentous fimbriae and sparse, white, spine-like fimbriae (Fig 3). Most cells showed concave pores at one pole (Fig 4). The bacteria were non-flagellated and non-spore-forming.
Fig 1. Gram-positive staining of Lactobacillus delbrueckii subsp. sunkii (digitally scanned at 40 × magnification).

Fig 2. Morphological structure of Lactobacillus delbrueckii subsp. sunkii under scanning electron microscopy (SEM).

Fig 3. SEM micrograph of Lactobacillus delbrueckii subsp. sunkii surface features.

Fig 4. SEM image showing concave pores on Lactobacillus delbrueckii subsp. sunkii cells.

H2O2 test and biochemical reaction results of GP and GN identification cards
The L. delbrueckii subsp. sunkii tested negative in the H2O2 test. The GP bacterial identification card yielded positive results for all of the following: arginine dihydrolase 1 (ADH1), α-glucosidase (AGLU), alanine-phenylalanine-proline arylamidase (APPA), α-galactosidase (AGAL), alanine arylamidase (AlaA), D-maltose (dMAL), D-mannitol (dMAN), D-mannose (dMNE), salicin (SAL), sucrose (SAC), arginine dihydrolase 2 (ADH2s), and optochin tolerance (OPTO). For the GN bacterial identification card, positive reactions were noted for APPA, D-glucose (dGLU), dMAN, dMNE, D-sorbitol (dSOR), and SAC, whereas negative reactions were noted for D-cellobiose (dCEL), L-proline arylamidase (ProA), and coumarate (CMT).
Acid production, antibacterial activity, and antibiotic susceptibility results
After 48 hours, the glucose concentration in each of the 10 tubes containing 5 mL of nutrient broth medium decreased from 277 ± 5 mmol/L to 138 ± 5 mmol/L. The pH of the medium dropped from 7.8 ± 0.2 to 4.0 ± 0.2. After 48 hours of incubation on blood agar plates, visible inhibition of E. coli (S2 Fig) and S. aureus (S3 Fig) was observed, along with inhibition of S. agalactiae growth. The mean antibiotic susceptibility results for L. delbrueckii subsp. sunkii from three tests were compared with those of control strains. After confirmation by both broth microdilution and disk diffusion, only the sulfonamide agents showed resistance by both methods and were ultimately classified as resistant, but the strain remained susceptible to 7 other tested antibiotics (Table 1).
Table 1. Antimicrobial susceptibility of Lactobacillus delbrueckii subsp. sunkii against 20 antibiotics (mean ± SD).
| Type of drug | Kirby–Bauer streaking method | Zone of inhibition (diameter, mm) | Dilution method | MIC value (µg/mL) |
Results | ||
|---|---|---|---|---|---|---|---|
| ID/content (μg) | Name | ID | Name | ||||
| Oxazolidinones | LNZ 30 | Linezolid | 40 ± 2 | LNZ | Linezolid | ≤2 | Sensitive |
| Quinolones | CIP 5 | Ciprofloxacin | 18 ± 2 | CIP | Ciprofloxacin | ≥2 | – |
| Quinolones | LVX 5 | Levofloxacin | 20 ± 2 | LVX | Levofloxacin | 8 | – |
| Quinolones | GAT 5 | Gatifloxacin | 26 ± 2 | – | – | – | – |
| Tetracyclines | TCY 30 | Tetracycline | 28 ± 2 | TCY | Tetracycline | ≤1 | – |
| Rifamycins | RIF 5 | Rifampicin | 25 ± 2 | RIF | Rifampicin | ≤0.5 | – |
| Chloramphenicols | CHL 30 | Chloramphenicol | 36 ± 2 | – | – | – | – |
| Penicillins | AMP 10 | Ampicillin | 40 ± 1 | AMP | Ampicillin | ≤0.25 | Sensitive |
| Penicillins | PEN 10 | Penicillin | 47 ± 2 | PEN | Penicillin | ≤0.06 | Sensitive |
| Glycopeptides | VAN 30 | Vancomycin | 30 ± 1 | VAN | Vancomycin | ≤1 | Sensitive |
| Aminoglycosides | GEN 10 | Gentamicin | 21 ± 2 | GEN | High-level gentamicin | ≤500 | – |
| Aminoglycosides | AMK 30 | Amikacin | 22 ± 1 | – | – | – | – |
| Lincosamides | CLI 2 | Clindamycin | 26 ± 1 | CLI | Clindamycin | ≤0.25 | Sensitive |
| Cephalosporins (3rd generation) | CRO 30 | Ceftriaxone | 36 ± 1 | CRO | Ceftriaxone | ≤0.5 | – |
| Cephalosporins (4th generation) | FEP 30 | Cefepime | 40 ± 1 | – | – | – | – |
| Cephalosporins (3rd generation) | CTX 30 | Cefotaxime | 41 ± 2 | – | – | – | – |
| Macrolides | ERY 15 | Erythromycin | 41 ± 2 | ERY | Erythromycin | ≤0.25 | Sensitive |
| Sulfonamides | SXT 25 | Trimethoprim/ Sulfamethoxazole |
6 ± 0 | SXT | Trimethoprim/Sulfamethoxazole | ≥4/76 | Resistant |
| Carbapenems | IPM 10 | Imipenem | 49 ± 2 | – | – | – | – |
| Carbapenems | MEM 10 | Meropenem | 40 ± 1 | MEM | Meropenem | ≤0.25 | Sensitive |
Note: “-” indicates that no result is available or the result cannot be determined.
16S rRNA gene alignment analysis
The 16S rRNA gene amplicon was sequenced by Sanger sequencing, and BLAST alignment against the NCBI database revealed 99.86% sequence identity to L. delbrueckii subsp. sunkii. The identified species was named L. delbrueckii subsp. sunkii WuYi 2021−1. The phylogenetic tree was constructed using the top 12 species with the highest sequence similarity in the database and is shown in S4 Fig. The bootstrap values for the upper and lower nodes of the phylogenetic tree are 10.9380% and 86.2646%, respectively, with only the lower node considered reliable (bootstrap value >70%). The tree shows that L. delbrueckii subsp. sunkii is phylogenetically related to five strains: L. delbrueckii subsp. sunkii NRIC 0767, L. delbrueckii subsp. sunkii CIRM BIA 266, L. delbrueckii subsp. indicus strain NCC 725, L. delbrueckii subsp. bulgaricus ATCC 11842 JCM 1002, and L. delbrueckii subsp. bulgaricus strain NBRC 13953.
Whole-genome sequencing results
A total of 1,906 coding genes were predicted from the whole-genome sequence (S2 Table). The numbers of annotated coding genes in the NR, KEGG, GO, COG, CAZy, Pfam, and Swiss-Prot databases were 1,888, 1,007, 1,232, 1,540, 216, 1,591, and 1,434, respectively. The COG database annotated a total of five genes: DnaA, DnaN, YbcJ, RecF, and GyrB. DnaA encodes an ATPase involved in DNA replication initiation; DnaN encodes the DNA polymerase sliding clamp subunit; YbcJ encodes an S4-like RNA-binding protein; RecF encodes a recombinational DNA repair ATPase (of the RecF pathway); and GyrB encodes the B subunit of type II topoisomerase (DNA gyrase/topo II, topoisomerase IV). These genes showed sequence identity ranging from 32.45% to 62.38% and all belong to the functional categories of DNA replication, recombination, and repair (S5 Fig). The CAZy database annotated genes in descending order of gene count: glycosyl transferases (GTs), glycoside hydrolases (GHs), carbohydrate-binding modules (CBMs), carbohydrate esterases (CEs), and auxiliary activities (AAs) with five related enzymes (S6 Fig). KEGG categorizes biological metabolic pathways into six major groups: Cellular Processes, Environmental Information Processing, Genetic Information Processing, Human Diseases, Metabolism, and Organismal Systems. Among these, the predominant category was Metabolism (S7 Fig). The GO annotation results cover three main categories: molecular function, biological process, and cellular component. Molecular function mainly includes catalytic activity, binding, and transporter activity. Biological process primarily encompassed metabolic process, cellular process, localization, biological regulation, and cellular component organization or biogenesis. Cellular component mainly refers to cell parts and protein-containing complexes (S8 Fig). The NR database annotated genes, including DNA polymerase III subunit beta, S4 domain-containing protein YaaA, DNA replication/repair protein RecF, and genes related to the ATP-hydrolyzing subunit B of DNA topoisomerase; based on the functions of these four genes, L. delbrueckii was the species with the highest annotation proportion (S9 Fig). Non-coding RNAs included 27 rRNAs, 94 tRNAs, and 27 other ncRNAs. Antibiotic resistance genes annotated using the CARD database are summarized in Fig 5. Additional analyses predicted 5 secretory proteins, 5 transmembrane proteins, 4 CRISPR arrays, and 1 prophage. The total number of raw bases generated by third-generation sequencing was 1,582,988,462 bp, the N content was 0.00%, and the number of sequences was 293,269. After assembly, the final genome size was 2,076,116 bp, with a GC content of 50.00%, an average sequencing depth of 705.62 × , 100% genome coverage, an N50 of 2,076,116 bp, and a BUSCO completeness of 98.5%. Comprehensive analysis results are summarized in S2 Table. The circular genome map in S10 Fig shows the genes, ncRNA, GC content, and repeat sequence data of L. delbrueckii subsp. sunkii.
Fig 5. CARD antibiotic resistance gene distribution.

Note: Pie chart segments colored by ARO (Antibiotic Resistance Ontology) categories, with segment sizes indicating relative gene proportions.
Virulence factor annotation results
A total of 1,906 predicted proteins from the L. delbrueckii subsp. sunkii strain were used as queries against the VFDB Set A and Set B protein databases. The searches yielded 4,266 initial hits from Set A and 15,263 from Set B, corresponding to 362 and 447 query proteins, respectively. Using strict filtering criteria (amino acid identity ≥ 80%, VFDB reference sequence coverage ≥ 70%, and E-value ≤ 1 × 10-5) [22], no homologs were detected in either dataset. Using extended criteria (40% ≤ amino acid identity < 80%, both query and reference coverage ≥ 70%, and E-value ≤ 1 × 10-5) [23], a total of 83 non-redundant VFDB homologs were identified. Of these, 42 were supported by both Set A and Set B, while 41 were supported only by Set B. Based on the best hits for each protein in Set B, VFDB functional classification was performed. The annotated homologs were mainly distributed across categories such as immune evasion/modulation, nutritional/metabolic factors, adhesion, regulation, and stress survival.
Discussion
According to the BioSample records in the NCBI Taxonomy Browser, the primary sources of the six subspecies of L. delbrueckii are as follows: L. delbrueckii subsp. sunkii [3,24,25] has been isolated predominantly from non-salted pickles and dairy products; L. delbrueckii subsp. bulgaricus [6,26] has been isolated from Bulgarian yogurt and kefir; L. delbrueckii subsp. delbrueckii has been found in fermented potatoes and cereal-based substrates; L. delbrueckii subsp. lactis [27] has been associated with milk and cheese production; L. delbrueckii subsp. indicus [28] has been isolated from dairy products; and L. delbrueckii subsp. jakobsenii [4] has been sourced from alcoholic fermented beverages. L. delbrueckii subsp. sunkii was first isolated in 2011 from Japanese non-salted pickles [3]. In 2021, we isolated this strain from the vaginal secretions of pregnant women. It was deposited in the China Center for Type Culture Collection (CCTCC) on August 5, 2022, under the accession number CCTCC M 20221248, and was designated as WuYi 2021−1. The whole-genome sequence was submitted to the NCBI database on October 23, 2022 (BioProject accession: PRJNA893246). Additionally, a Chinese invention patent was granted for this discovery (Patent No. ZL202210967911.6).
The L. delbrueckii subsp. sunkii isolated from Japanese non-salted pickles is a Gram-positive, non-spore-forming, facultatively anaerobic bacillus, typically 2.0–5.0 μm long, arranged singly, in pairs, or as short chains of 3–4 cells [3]. Kudo et al. [3] found that this strain grew weakly in MRS broth at 15 °C and showed no growth at 45 °C; on MRS agar under anaerobic incubation at 30 °C for 48 hours, colonies appeared cream-colored with smooth to rough surfaces, circular or irregular shapes, and diameters of 2–4 mm. Physiological traits: the optimal pH for growth is around 4.0; weak growth occurs in 4% NaCl. The strain is catalase-negative and produces acid from glucose without gas (final product: D-lactate) [3]. Ammonia is produced from L-arginine. Nitrate reduction is negative. Carbohydrate utilization: ferments fructose, mannose, mannitol, N-acetyl-D-glucosamine, cellobiose, maltose, melibiose, sucrose, D-trehalose, raffinose, gentiobiose, and salicin. Acid production is D-galactose-dependent. The strain hydrolyzes esculin [3]. In comparison, the L. delbrueckii subsp. sunkii strain that we isolated from the vaginal secretions of pregnant women appeared as Gram-positive short or long rods, which were non-flagellated and non-spore-forming. On modified blood agar, colonies are moist with smooth margins and slightly raised edges, show central depressions, and exhibit α-hemolysis. SEM reveals cells averaging 1–10 μm in length, resembling Cordyceps or silkworms. The surface of the bacterial cells was covered with a few filamentous fimbriae and white, spine-like fimbriae, and the cells were surrounded by filamentous fimbriae shed from the bacteria. Most cells exhibited a concave pore at one end. Biochemical characteristics: The hydrogen peroxide test was negative. The strain ferments dGLU, dMAL, dMNE, dMAN, SAC, and SAL but not dCEL, ProA, or CMT. The strain produces AGAL, AGLU, dSOR, ADH1, ADH2s, AlaA, APPA, and exhibits OPTO. These biochemical test results may be related to the function of GHs annotated for the bacterium in the CAZy database. GHs are enzymes that hydrolyze glycosidic bonds in various sugar-containing compounds, generating monosaccharides, oligosaccharides, or sugar complexes. Growth adaptation: The optimal growth temperature is 35 °C (close to human body temperature), and it thrives in blood medium containing 5% NaCl. Significant morphological and biochemical differences have been reported between subspecies strains from distinct sources, highlighting environmental adaptability.
The strain, when cultured on modified blood agar for 48 hours, exhibited a significant inhibitory effect on the growth of S. aureus and E. coli. Additionally, it formed a regular concentric α-hemolytic ring when co-cultured with S. aureus. We also observed that the growth of L. delbrueckii subsp. sunkii was inhibited by S. agalactiae in the culture medium. However, after producing a large amount of lactic acid, the strain in turn inhibited the growth of S. agalactiae. Kamble et al. [29] found that L. delbrueckii could inhibit the growth of hemolytic Staphylococcus, E. coli, and Enterococcus faecalis. Abedi et al. [30] reported that L. delbrueckii subsp. bulgaricus could inhibit E. coli infection in the intestine and exhibited anti-adhesion effects. The L. delbrueckii subsp. sunkii strain isolated from the human body tested negative in the hydrogen peroxide assay. However, it was capable of fermenting carbohydrates to produce acid, reducing the pH from 7.8 to around 4.0, thereby inhibiting the growth of pathogenic bacteria and preventing the overgrowth of opportunistic pathogens. This indicates a strong acid-producing capacity. Li et al. [31] discovered that the dapA, dapH, and lysC genes were the key factors contributing to the acid resistance of L. delbrueckii subsp. bulgaricus. Our previous research also found that the microbial population in the vaginal secretions of pregnant women was significantly lower than that of women with no history of sexual activity. A comparative analysis of strains revealed the absence of L. delbrueckii in the vaginal secretions of women with no history of sexual activity. This suggests that the bacterium may play an important role in vaginal self-cleaning and in maintaining the balance of vaginal microbiota. Additionally, the strain can lyse red blood cells in blood agar, forming an α-hemolytic ring, which may contribute to clearing residual menstrual blood in the vagina. The top 10 CARD-annotated antibiotic resistance genes in this strain were identified as those conferring resistance to macrolides, tetracyclines, peptides, lincosamides, glycopeptides, penams, fluoroquinolones, streptogramins, nitroimidazoles, and pleuromutilins. However, antibiotic susceptibility testing showed resistance only to sulfonamides, while the strain remained susceptible to 7 other commonly used antibiotics. This indicates a discrepancy between genotype and phenotype, which requires further experimental validation. These findings also suggest that most clinical antibiotics can negatively impact the growth and reproduction of L. delbrueckii subsp. sunkii, leading to a reduction in its population. This, in turn, could disrupt vaginal microbiota balance, potentially causing vaginitis and even affecting fetal development. Therefore, the use of antibiotics during pregnancy should be avoided. We followed the published WGS-based safety evaluation process for probiotic lactobacilli and applied strict screening thresholds. Initially, no virulence factors were annotated in the VFDB database, further suggesting that L. delbrueckii subsp. sunkii is a probiotic and non-pathogenic organism. Although annotations were found for immune modulation, nutritional/metabolic factors, adhesion, regulation, and stress survival, these annotations do not indicate pathogenicity; rather, they reflect positive immunomodulatory functions. For example, L. delbrueckii subsp. sunkii can inhibit the growth and reproduction of pathogenic bacteria by adhering to vaginal squamous epithelial cells, thereby exerting its adhesive function; it can also break down glycogen in vaginal epithelial cells to produce lactate, which contributes to its nutritional metabolic function [32]. The results of the antimicrobial susceptibility testing showed that gentamicin and amikacin (both aminoglycosides) may be sensitive to phenotype, which may be associated with the functions of glycosyltransferases (GTs) and glycoside hydrolases (GHs) annotated in the CAZy database. The core function of GTs is to catalyze glycosylation reactions. Glycoside antibiotics are glycosylated by glycosyltransferases in vivo, and the position, type, and number of glycosides have a significant impact on the activity of these antibiotics. Shani et al. [33] studied L. delbrueckii subsp. lactis and found that 52.1% of kanamycin minimum inhibitory concentrations (MICs), 9.9% of chloramphenicol MICs, and 5.6% of tetracycline MICs exceeded microbiological cutoffs (MCs). However, no antibiotic resistance genes (ARGs) were detected. De Jesus et al. [34] observed that L. delbrueckii subsp. lactis CIDCA 133 was resistant to streptomycin and gentamicin (both aminoglycosides), but the strain did not show hemolytic or mucin-degrading activity.
Different subspecies of L. delbrueckii have been reported to contribute to varying extents in clinical disease diagnosis, treatment, and industrial applications. Macho-Aizpurua et al. [35] reported a case of urinary tract-derived bacteremia caused by L. delbrueckii subsp. sunkii. Probiotics are known to modulate pathogen virulence; for instance, L. delbrueckii subsp. lactis CIDCA 133 may exert beneficial effects during Bacillus cereus infection of intestinal epithelial cells [36]. Wang et al. [37] demonstrated that L. delbrueckii subsp. bulgaricus LDSB-KSFY07 inhibits thrombosis in mice and reduces hepatic oxidative stress damage. The L. delbrueckii subsp. bulgaricus strain TCI904 mitigates high-fat diet-induced obesity in mice by regulating immune responses, improving metabolic profiles, and alleviating anxiety [38]. Ishikawa et al. [39] revealed that exopolysaccharides (EPS) produced by L. delbrueckii subsp. bulgaricus OLL1073R-1 prevented influenza virus infection, reduced secondary bacterial infection risks, and enhanced humoral immunity in influenza A-infected mice. However, this immune enhancement is suppressed by neuraminidase inhibitors such as oseltamivir [40]. Li et al. [41] identified nattokinase from L. delbrueckii subsp. bulgaricus as a potent thrombolytic agent in vitro, highlighting its potential for developing functional fermented dairy products. Hallajzadeh et al. [42] proposed L. delbrueckii subsp. lactis PTCC1057 as a promising candidate for future diabetes research.
Since the whole-genome sequences of L. delbrueckii subsp. sunkii currently recorded in gene databases are all derived from external environments, we conducted whole-genome sequencing to gain a comprehensive understanding of the nucleotide sequence of L. delbrueckii subsp. sunkii in the human body. A total of 1,906 coding genes were predicted from the whole-genome sequence. The numbers of annotated coding genes in the NR, KEGG, GO, COG, CAZy, Pfam, and Swiss-Prot databases were 1,888, 1,007, 1,232, 1,540, 216, 1,591, and 1,434, respectively. Additionally, we predicted 27 rRNA genes, 94 tRNA genes, and 27 other ncRNA genes. Furthermore, 5 secreted proteins, 5 transmembrane proteins, 4 CRISPR sequences, and 1 prophage were identified. The gene set identified for this bacterium in the COG, GO, and KEGG databases can be divided into two major functional modules: one module focuses on genetic information processing, including DNA replication, damage repair, and maintenance of genome homeostasis; the other part is involved in amino acid biosynthesis and has the potential to synthesize secondary metabolites such as β-lactams, providing a functional basis for subsequent analysis of the genetic and metabolic characteristics of the strain. The genes annotated in COG are mainly responsible for replication initiation, DNA damage repair and recombination, and maintenance of genome topology, playing a core role in ensuring genome stability. KEGG annotations indicate that some genes are mainly involved in amino acid biosynthesis, while others are involved in the synthesis of secondary metabolites. The signaling pathways and gene functions annotated in the KEGG and COG databases are primarily associated with metabolism, strongly suggesting that this bacterium functions as a probiotic in the human body. The BLAST alignment results from the NCBI database show a 99.86% sequence identity between our strain’s DNA sequences and those of L. delbrueckii subsp. sunkii, indicating that there are still some differences in the nucleotide sequences among strains from different sources. Sprotte et al. [43] isolated a novel L. delbrueckii subsp. bulgaricus phage, PMBT4, from fermented dairy products in Nigeria. The phage has a slender, non-contractile tail and an isometric head, indicating that it belongs to the family Siphoviridae. Similarly, we predicted a prophage in our strain, but its function and role remain unknown. Further research will be conducted to explore its gene functions in detail, laying the foundation for the development of L. delbrueckii subsp. sunkii microecological preparations.
Conclusions
The morphological characteristics, biochemical reactions, and nucleotide sequences of L. delbrueckii subsp. sunkii from different sources vary. Not all L. delbrueckii strains can produce H2O2, and L. delbrueckii subsp. sunkii has a strong capacity to ferment carbohydrates and produce acid. It is sensitive to most antibiotics, with a discrepancy between its genotype (resistance genes) and its phenotypic resistance profile. Sulfonamides do not affect the growth or reproduction of L. delbrueckii subsp. sunkii. We suggest that this strain may be associated with human metabolism and vaginal microbiota balance. Due to the limitations of in vitro experiments, animal studies are needed to further simulate the human vaginal environment. Therefore, animal model construction will be carried out in subsequent studies.
Supporting information
(TIF)
Note: A. Experimental group (E. coli colony diameter: 6 mm); B. Control group (E. coli colony diameter: 20 mm).
(TIF)
Note: A. Experimental group (S. aureus colony diameter: 4 mm); B. Control group (S. aureus colony diameter: 12 mm).
(TIF)
Note: The branch length represents the evolutionary distance, with more closely related species positioned closer together on the phylogenetic tree. The branch length also reflects the degree of sequence differentiation among strains, with larger values indicating greater differentiation.
(TIFF)
Note: X-axis: COG functional categories; Y-axis: number of annotated genes per category. Explanations for each category are provided on the right.
(TIF)
Note: X-axis: CAZy family classifications; Y-axis: gene counts.
(TIF)
Note: Y-axis: secondary classifications of biological pathways; X-axis: gene counts. Colors represent primary pathway categories.
(TIF)
Note: Y-axis: GO terms; X-axis: gene counts. Colors distinguish Biological Process (BP), Cellular Component (CC), and Molecular Function (MF).
(TIF)
Note: Pie chart showing species proportions, with colors representing distinct taxa.
(TIF)
Note: Concentric circles display the following, from outermost to innermost: outermost circle: genomic coordinates; second circle: GC content; third circle: coding genes on the positive strand (red); fourth circle: coding genes on the negative strand (green); fifth circle: non-coding RNAs (ncRNAs) on the positive strand (blue); sixth circle: ncRNAs on the negative strand (purple); innermost circle: long repetitive sequences (orange).
(TIF)
(DOCX)
(DOCX)
Acknowledgments
We thank Professor Guanwu Li from the Department of Biochemistry and Molecular Biology at Shantou University Medical College for his help.
Abbreviations
- CARD
Comprehensive Antibiotic Resistance Database
- GN
Gram-negative
- GP
Gram-positive
- K-B
Kirby-Bauer
- CLSI
Clinical and Laboratory Standards Institute
- SEM
scanning electron microscopy
- CCTCC
China Center for Type Culture Collection
- MICs
minimum inhibitory concentrations
- MCs
microbiological cutoffs
- ARGs
antibiotic resistance genes
- EPS
exopolysaccharides
- ARO
Antibiotic Resistance Ontology
- BP
biological process
- CC
cellular component
- MF
molecular function
Data Availability
The genome sequence was deposited in the NCBI database under accession number PRJNA893246 (https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA893246). The strain is preserved at CCTCC (No. CCTCC M 20221248). Supplementary figures and tables are provided in the online version.
Funding Statement
This work was supported by the Shenzhen Yantian District Science and Technology Innovation Bureau (No. YTWS 20230203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Shah AB, Baiseitova A, Zahoor M, Ahmad I, Ikram M, Bakhsh A, et al. Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects. Gut Microbes. 2024;16(1):2431643. doi: 10.1080/19490976.2024.2431643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tanigawa K, Watanabe K. Multilocus sequence typing reveals a novel subspeciation of Lactobacillus delbrueckii. Microbiology (Reading). 2011;157(Pt 3):727–38. doi: 10.1099/mic.0.043240-0 [DOI] [PubMed] [Google Scholar]
- 3.Kudo Y, Oki K, Watanabe K. Lactobacillus delbrueckii subsp. sunkii subsp. nov., isolated from sunki, a traditional Japanese pickle. Int J Syst Evol Microbiol. 2012;62(Pt 11):2643–9. doi: 10.1099/ijs.0.037051-0 [DOI] [PubMed] [Google Scholar]
- 4.Adimpong DB, Nielsen DS, Sørensen KI, Vogensen FK, Sawadogo-Lingani H, Derkx PMF, et al. Lactobacillus delbrueckii subsp. jakobsenii subsp. nov., isolated from dolo wort, an alcoholic fermented beverage in Burkina Faso. Int J Syst Evol Microbiol. 2013;63(Pt 10):3720–6. doi: 10.1099/ijs.0.048769-0 [DOI] [PubMed] [Google Scholar]
- 5.Baek M-G, Kim KW, Yi H. Subspecies-level genome comparison of Lactobacillus delbrueckii. Sci Rep. 2023;13(1):3171. doi: 10.1038/s41598-023-29404-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dan T, Ren W, Liu Y, Tian J, Chen H, Li T, et al. Volatile Flavor Compounds Profile and Fermentation Characteristics of Milk Fermented by Lactobacillus delbrueckii subsp. bulgaricus. Front Microbiol. 2019;10:2183. doi: 10.3389/fmicb.2019.02183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Akermann A, Weiermüller J, Christmann J, Guirande L, Glaser G, Knaus A, et al. Brewers’ spent grain liquor as a feedstock for lactate production with Lactobacillus delbrueckii subsp. lactis. Eng Life Sci. 2020;20(5-6):168–80. doi: 10.1002/elsc.201900143 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yue Y, Wang S, Lv X, Wang C, Xu B, Ping L, et al. Analysis of the complete genome sequence of Lactobacillus delbrueckii ssp. bulgaricus with post-acidification capacity and its influence on yogurt in storage. J Dairy Sci. 2022;105(2):1058–71. doi: 10.3168/jds.2021-20999 [DOI] [PubMed] [Google Scholar]
- 9.Song Y, Zhao J, Liu W, Li W, Sun Z, Cui Y, et al. Exploring the industrial potential of Lactobacillus delbrueckii ssp. bulgaricus by population genomics and genome-wide association study analysis. J Dairy Sci. 2021;104(4):4044–55. doi: 10.3168/jds.2020-19467 [DOI] [PubMed] [Google Scholar]
- 10.Mo J, Lu Y, Jiang S, Yan G, Xing T, Xu D, et al. Effects of the Probiotic, Lactobacillus delbrueckii subsp. bulgaricus, as a Substitute for Antibiotics on the Gastrointestinal Tract Microbiota and Metabolomics Profile of Female Growing-Finishing Pigs. Animals (Basel). 2022;12(14):1778. doi: 10.3390/ani12141778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Suda Y, Sasaki N, Kagawa K, Elean M, Zhou B, Tomokiyo M, et al. Immunobiotic Feed Developed with Lactobacillus delbrueckii subsp. delbrueckii TUA4408L and the Soymilk By-Product Okara Improves Health and Growth Performance in Pigs. Microorganisms. 2021;9(5):921. doi: 10.3390/microorganisms9050921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Goo RY, Li MS. Proposal of Sphingobacterium allocomposti nom. nov., Mycobacterium chelonae subsp. bovistauri nom. nov. and Lactobacillus delbrueckii subsp. allosunkii nom. nov. as new names with replacement specific or subspecific epithets, respectively, for three illegitimate prokaryotic names Sphingobacterium composti Yoo et al. 2007, Mycobacterium chelonae subsp. bovis Kim et al. 2017 and Lactobacillus delbrueckii subsp. sunkii Kudo et al. 2012; proposal of Christiangramia oceanisediminis comb. nov. and Christiangramia crocea comb. nov. as replacement names respectively for two illegitimate prokaryotic names Gramella oceanisediminis Yang et al. 2023 and Gramella crocea Zhang et al. 2023. Int J Syst Evol Microbiol. 2024;74(4). doi: 10.1099/ijsem.0.006319 [DOI] [PubMed] [Google Scholar]
- 13.Chin C-S, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods. 2013;10(6):563–9. doi: 10.1038/nmeth.2474 [DOI] [PubMed] [Google Scholar]
- 14.Koren S, Walenz BP, Berlin K, Miller JR, Bergman NH, Phillippy AM. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res. 2017;27(5):722–36. doi: 10.1101/gr.215087.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chin C-S, Peluso P, Sedlazeck FJ, Nattestad M, Concepcion GT, Clum A, et al. Phased diploid genome assembly with single-molecule real-time sequencing. Nat Methods. 2016;13(12):1050–4. doi: 10.1038/nmeth.4035 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One. 2014;9(11):e112963. doi: 10.1371/journal.pone.0112963 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hyatt D, Chen G-L, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010;11:119. doi: 10.1186/1471-2105-11-119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421. doi: 10.1186/1471-2105-10-421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19(9):1639–45. doi: 10.1101/gr.092759.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis--10 years on. Nucleic Acids Res. 2016;44(D1):D694-7. doi: 10.1093/nar/gkv1239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Buchfink B, Reuter K, Drost H-G. Sensitive protein alignments at tree-of-life scale using DIAMOND. Nat Methods. 2021;18(4):366–8. doi: 10.1038/s41592-021-01101-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.European Food Safety Authority EFSA. EFSA statement on the requirements for whole genome sequence analysis of microorganisms intentionally used in the food chain. EFSA J. 2024;22(8):e8912. doi: 10.2903/j.efsa.2024.8912 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Liu Y, Zheng H, Wang J, Xin J, Wu R, Zhang J, et al. Whole genome analysis and in vivo safety assessment of probiotic candidate Lactobacillus acidophilus L177. BMC Microbiol. 2025;25(1):398. doi: 10.1186/s12866-025-04099-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Güley Z, Fallico V, Cabrera-Rubio R, Cotter PD, Beresford T. Identification of Streptococcus infantarius subsp. infantarius as the species primarily responsible for acid production in Izmir Brined Tulum Cheese from the Aegean Region of Türkiye. Food Res Int. 2022;160:111707. doi: 10.1016/j.foodres.2022.111707 [DOI] [PubMed] [Google Scholar]
- 25.Meloni MP, Piras F, Siddi G, Cabras D, Comassi E, Lai R, et al. Comparison of Activity of Commercial Protective Cultures and Thermophilic Lactic Acid Bacteria against Listeria monocytogenes: A New Perspective to Improve the Safety of Sardinian PDO Cheeses. Foods. 2023;12(6):1182. doi: 10.3390/foods12061182 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Alexandraki V, Kazou M, Pot B, Tsakalidou E, Papadimitriou K. Complete genome sequence of the yogurt isolate Lactobacillus delbrueckii subsp. bulgaricus ACA-DC 87. Genome Announcements. 2017;5(34):e00868-17. doi: 10.1128/genomeA.00868-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.El Kafsi H, Binesse J, Loux V, Buratti J, Boudebbouze S, Dervyn R, et al. Lactobacillus delbrueckii ssp. lactis and ssp. bulgaricus: a chronicle of evolution in action. BMC Genomics. 2014;15(1):407. doi: 10.1186/1471-2164-15-407 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Dellaglio F, Felis GE, Castioni A, Torriani S, Germond J-E. Lactobacillus delbrueckii subsp. indicus subsp. nov., isolated from Indian dairy products. Int J Syst Evol Microbiol. 2005;55(Pt 1):401–4. doi: 10.1099/ijs.0.63067-0 [DOI] [PubMed] [Google Scholar]
- 29.Kamble A, Naik S, Talathi M, Jadhav D, Pingale S, Kaul-Ghanekar R. Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients. Arch Microbiol. 2022;204(8):491. doi: 10.1007/s00203-022-03103-5 [DOI] [PubMed] [Google Scholar]
- 30.Abedi D, Feizizadeh S, Akbari V, Jafarian-Dehkordi A. In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res Pharm Sci. 2013;8(4):260–8. [PMC free article] [PubMed] [Google Scholar]
- 31.Li W, Yang L, Nan W, Lu J, Zhang S, Ujiroghene OJ, et al. Whole-genome sequencing and genomic-based acid tolerance mechanisms of Lactobacillus delbrueckii subsp. bulgaricus LJJ. Appl Microbiol Biotechnol. 2020;104(17):7631–42. doi: 10.1007/s00253-020-10788-5 [DOI] [PubMed] [Google Scholar]
- 32.Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol. 2002;93(5):884–93. doi: 10.1046/j.1365-2672.2002.01759.x [DOI] [PubMed] [Google Scholar]
- 33.Shani N, Oberhaensli S, Berthoud H, Schmidt RS, Bachmann H-P. Antimicrobial Susceptibility of Lactobacillus delbrueckii subsp. lactis from Milk Products and Other Habitats. Foods. 2021;10(12):3145. doi: 10.3390/foods10123145 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.de Jesus LCL, de Jesus Sousa T, Coelho-Rocha ND, Profeta R, Barroso FAL, Drumond MM, et al. Safety evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a health-promoting bacteria. Probiotics Antimicrob Proteins. 2022;14(5):816–29. doi: 10.1007/s12602-021-09826-z [DOI] [PubMed] [Google Scholar]
- 35.Macho-Aizpurua M, Angulo-López I, Arciniega-García JM, Díaz-de-Tuesta Del-Arco JL. Bacteriemia de origen urinario por Lactobacillus delbrueckii ssp. sunkii. Rev Esp Quimioter. 2021;34(4):400–1. doi: 10.37201/req/029.2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rolny IS, Tiscornia I, Racedo SM, Pérez PF, Bollati-Fogolín M. Lactobacillus delbrueckii subsp lactis CIDCA 133 modulates response of human epithelial and dendritic cells infected with Bacillus cereus. Benef Microbes. 2016;7(5):749–60. doi: 10.3920/BM2015.0191 [DOI] [PubMed] [Google Scholar]
- 37.Wang P, Tan F, Mu J, Chen H, Zhao X, Xu Y. Inhibitory Effect of Lactobacillus delbrueckii subsp. bulgaricus KSFY07 on Kappa-Carrageenan-Induced Thrombosis in Mice and the Regulation of Oxidative Damage. Cardiovasc Ther. 2022;2022:4415876. doi: 10.1155/2022/4415876 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lin Y-K, Lin Y-H, Chiang C-F, Yeh T-M, Shih W-L. Lactobacillus delbrueckii subsp. bulgaricus strain TCI904 reduces body weight gain, modulates immune response, improves metabolism and anxiety in high fat diet-induced obese mice. 3 Biotech. 2022;12(12):341. doi: 10.1007/s13205-022-03356-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ishikawa H, Kuno Y, Kohda C, Sasaki H, Nagashima R, Iyoda M. Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 prevent influenza virus infection and attenuate secondary bacterial infection risk. Lett Appl Microbiol. 2022;74(5):632–9. doi: 10.1111/lam.13649 [DOI] [PubMed] [Google Scholar]
- 40.Takahashi E, Sawabuchi T, Kimoto T, Sakai S, Kido H. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice. J Dairy Sci. 2019;102(11):9559–69. doi: 10.3168/jds.2019-16268 [DOI] [PubMed] [Google Scholar]
- 41.Li C, Du Z, Qi S, Zhang X, Wang M, Zhou Y, et al. Food-grade expression of nattokinase in Lactobacillus delbrueckii subsp. bulgaricus and its thrombolytic activity in vitro. Biotechnol Lett. 2020;42(11):2179–87. doi: 10.1007/s10529-020-02974-2 [DOI] [PubMed] [Google Scholar]
- 42.Hallajzadeh J, Eslami RD, Tanomand A. Effect of Lactobacillus delbrueckii Subsp. lactis PTCC1057 on Serum Glucose, Fetuin-A, and Sestrin 3 Levels in Streptozotocin-Induced Diabetic Mice. Probiotics Antimicrob Proteins. 2021;13(2):383–9. doi: 10.1007/s12602-020-09693-0 [DOI] [PubMed] [Google Scholar]
- 43.Sprotte S, Fagbemigun O, Brinks E, Cho G-S, Casey E, Oguntoyinbo FA, et al. Novel Siphoviridae phage PMBT4 belonging to the group b Lactobacillus delbrueckii subsp. bulgaricus phages. Virus Res. 2022;308:198635. doi: 10.1016/j.virusres.2021.198635 [DOI] [PubMed] [Google Scholar]
